Joint Care contains glucosamine, rosehip, echinacea, and vitamin C, and Supreme Petfoods says it's been developed in response to growing awareness of osteoarthritis (OA) as a significant yet under-diagnosed condition in small mammals.
Supreme points to a retrospective study which identified osteoarthritic lesions in 40% of domestic rabbits, with prevalence strongly correlated with age and body weight.¹
The company says that while definitive prevalence data in guinea pigs is lacking, OA is considered to be common in this species as well.²
Molly Varga, RCVS recognised exotics specialist, said: “Signs of joint pain are often subtle or masked in prey species.
"Proactive use of nutritional supplements like Science Selective Joint Care can help maintain mobility and may delay progression.
"Nutritional support, combined with appropriate husbandry and veterinary care, can make a real difference to long-term quality of life.”
As well as glucosamine, Science Selective Joint Care also contains rosehip, a botanical with claimed anti-inflammatory and chondroprotective properties and echinacea, which has claimed anti-inflammatory, antioxidant and immunomodulatory activity.3,4
Supreme says Vitamin C is an essential nutrient for guinea pigs and beneficial for rabbits, and contributes to normal collagen formation and may help protect joint tissues from oxidative stress.
Claire Hamblion, Marketing Director at Supreme Petfoods, said: “With 45% of pet owners now regularly purchasing supplements for their animals,5 the demand for clinically relevant, species-appropriate products is growing.
"We work closely with veterinary and nutrition experts to ensure our formulations meet emerging needs and Joint Care reflects that commitment.”
Available in 100g packs, Joint Care has a recommended retail price (RRP) of £6.99 and is suitable for rabbits, guinea pigs, and chinchillas.
https://supremepetfoods.com/products/science-selective-care-supplements
References
The BVA is calling on the UK Government to urgently develop a coherent, risk-based national strategy to close the gaps in border biosecurity and protect the UK from devastating diseases like African swine fever and foot-and-mouth disease.
The Environment, Food and Rural Affairs (EFRA) Committee report makes for sobering reading.
It reveals a lack of adequate border control enforcement when it comes to personal imports of meat and other products of animal origin, weak intelligence networks, poor Government interdepartmental working and an absence of a national strategy to manage the significant animal disease and public health risks posed by potentially contaminated products.
The report raises particular concerns about funding cuts for Official Vets at Dover, alongside ministerial comments that appear to dismiss the role of vets in protecting biosecurity.
British Veterinary Association Junior Vice President Rob Williams said: “This report is deeply concerning, exposing serious gaps in border enforcement and warning that large amounts of illegal and potentially contaminated meat continue to enter the UK and make their way on to our plates.
"We cannot know where this meat has come from or if it meets the UK’s high animal welfare and biosecurity standards, and without appropriate checks, we can’t stop illegal meat imports at the border.
"This could have catastrophic and costly impacts on the UK’s food security, public health, and animal health and welfare through the import of exotic animal diseases such as foot-and-mouth disease.
"The findings from this report, coupled with the recent National Audit Office report on animal disease resilience, should act as a wake-up call to Government to urgently deliver a coherent and properly resourced national strategy to tackle illegal meat imports and safeguard the UK’s biosecurity.
“Government vets play a critical role in protecting the nation’s biosecurity but can only do their jobs effectively if they are supported by effective systems.
"Currently, veterinary capacity required to perform checks remains a concern.
"As part of a national action plan, we would like to see better support for vets through a data-driven and risk-based system that is fit for purpose.
"This should also include adequate resources for Official Vets and the agencies tasked with keeping borders secure, which is why we want to see the proposed 70% cuts to Dover Port's budget for spot checks on animal products reversed.”
committees.parliament.uk/writtenevidence/135824/html/
Photo: www.depositphotos.com
The company conducted the survey of 404 owners after news that the bio-pharma company Okava plans to trial a weight-loss drug for dogs that mimics the effects of weight-loss drugs like Wegovy, tapping into a potential $10 billion market.
Of the pet owners who responded, it was the younger group aged 25-34 who were most receptive to the idea of a weight-loss drug for their pet (56%).
That figure fell to 21% of 45–54-year-olds and 20% among those aged 55 and above, most of whom were probably holding up their hands in horror: "Whatever next".
Alicia Hempsted, pet insurance spokeswoman from MoneySuperMarket, said: “If GLP-1 style treatments for obesity become available for dogs in the future, it’s likely that owners will have to pay out of pocket for them, which may affect their availability."
https://www.moneysupermarket.com/pet-insurance/
The awards are to celebrate outstanding veterinary practices that have demonstrated exceptional performance and innovation in various areas crucial to the future success of the profession.
There are three award categories, one to recognise leadership and management skills, one to celebrate practices that have excellent morale and a culture of collaborative teamworking, and one for practices that have started up in the last 2.5 years and achieved a profitable and sustainable business model.
The category winners will each win full day and evening tickets to SPVS Congress 2026 on Thursday 26th February at the Hilton Birmingham Metropole (3 team members per practice), plus overnight accommodation.
Five shortlisted practices in each category will win a book of their choice, provided by 5M Books.
The deadline for initial submissions is Friday 17th October 2025.
https://spvs.org.uk/business-excellence-awards/.
The authors say that measuring the severity of pterygoid bone medialisation before surgery may therefore be useful as a guide to the likely prognosis.
The study, funded by BSAVA PetSavers, is the first to investigate the effect of pterygoid bone medialisation and nasopharyngeal narrowing on BOAS surgical outcomes in brachycephalic and non-brachycephalic dogs.
Researchers at the University of Cambridge Department of Veterinary Medicine analysed computed tomography (CT) images of the head and neck of 144 brachycephalic dogs (French Bulldogs, Pugs and English Bulldogs) and compared with 30 non-brachycephalic control dogs.
A BOAS index was determined both pre-operatively and post-operatively.
Medialisation of the pterygoid bones was more severe in brachycephalic breeds compared to non-brachycephalic breeds and was associated with nasopharyngeal narrowing.
French Bulldogs were particularly affected, and those with more severe pterygoid bone medialisation were far more likely to have a poor BOAS surgical outcome.
There are currently no effective surgical interventions to correct the deformities of the pterygoid bones in BOAS-affected dogs.
The authors say medialisation of the pterygoid bones can be easily identified via CT scans, or alternatively, simple palpation of the pterygoid bone during surgery from the oral cavity can give an indication of how medialised the pterygoid bones are.
Dr. Sze Lynn Yuen, lead author of the study, said: “BOAS is a complex disease which encompasses breed-specific anatomical lesions.
"The medialisation index will be useful for vets in practice to guide them on the likely prognosis prior to surgery.
"It would be beneficial to identify the significance of the medialisation index on a larger dataset of BOAS-affected patients as the next step.”
https://onlinelibrary.wiley.com/doi/10.1111/jsap.70028
The keynote speaker on the Saturday this year is Helen Ballantyne, a renowned dual-qualified medical and veterinary nurse, currently working as a Transplant Coordinator for the NHS.
Bringing her rare perspective from both veterinary and human-centred nursing, Helen will highlight the progress made by the veterinary nursing profession, and its future potential.
There's a diverse programme of CPD lectures, debates on various hot topics including the CMA investigation and practical workshops covering things like: practical application of wound dressings, suturing skills, interactive CPR and preventing wound infections and AMR.
On top of all that, there's the usual commercial exhibition, bingo evening on the Friday, and a singing sixties-themed dinner dance on the Saturday.
https://bvna.org.uk/registration
The company says the battery-operated, dual-speed clipper has been specifically designed for a close cut to improve hygiene and make treatments easier.
Hefin Rowlands from Heiniger said: “The Opal Xtend will help vets with accurate hair removal for everyday tasks such as TB testing.
"It has been developed to be quieter, which will reduce stress, and has an interchangeable battery system to enable uninterrupted operation during periods of extensive use.
“An LED battery indicator provides forewarning to operators and additional batteries can be swapped out quickly and easily.
"Each battery will last up to 4 hours and the second battery only takes just over an hour to recharge.”
Heiniger claims that at 415 grams, the clipper is one of the lightest cordless models available.
Hefin added: “It is particularly well suited to preparing animals for skin testing, wound treatments and scans including ultrasounds.”
Heiniger says the clipper is also a good fit for agricultural and equine users looking for a reliable and dependable machine that can stand up to demanding use.
https://www.heiniger.co.uk/product/opal-xtend/
Anyone completing the BVRA Foundation Course will receive a joint BVRA/iPET Network Certificate of Achievement.
BVRA is also working on creating an Ofqual Regulated qualification in the sector, which will be available in the autumn 2023.
BVRA CEO, Kay Watson-Bray (pictured) said: “We have been listening to our members and their employers and identified the quality assurance that comes with regulation is a really important aspect of accredited CPD.
"This initiative will give veterinary receptionists the opportunity to gain an official qualification with transferable credits that they can use as a stepping stone to higher education and will provide a defined career path.”
The BVRA has also relaunched what was the Registered Veterinary Receptionist (RVR) as the new BVRA Associate Veterinary Receptionist (AVR).
Being an AVR gives BVRA members further membership benefits, training and status.
Kay added: “It’s an exciting time for veterinary receptionists who have previously had limited career path opportunities. BVRA is committed to provide the most up to date, relevant CPD created by industry experts.”
www.bvra.co.uk
To raise the funds, CVS put customer and staff collection boxes in its small animal first opinion practices and referral hospitals.
Staff also held a number of fundraising events – including sponsored walks and dog shows, as well as hosting Pet Blood Bank donation days.
The money raised from the partnership will help go towards funding Pet Blood Bank’s work.
Last year the charity sent over 5,000 units of blood to vets across the UK.
Pet Blood Bank provides training for vets and nurses, and donations also help the charity to keep the cost of blood products as low as possible, and provide them free to veterinary charities.
Deputy Chief Executive of CVS Group, Ben Jacklin, said: “Pet Blood Bank is a vital charity doing crucial work within our profession.
"There is no doubt that the level of funds raised is down to the tireless commitment shown by our colleagues up and down the country.
"I’d also like to recognise the role our clients have also made - as without them we would never have reached such a great total.”
Managing Director of Pet Blood Bank, Katrina Wilkinson said: “This generous donation from CVS Group has been incredible to receive.
"We are a small charity so need all the support we can get, and CVS has truly delivered."
CVS has recently announced its next charity partner as Guide Dogs for the Blind.
Skin diseases and palpable masses are a common presentation in guinea pigs brought for veterinary care2.
However, few studies have thus far looked at the prevalence of spontaneously arising diseases in pet guinea pigs.
"Lumpy bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology" retrospectively analysed 619 biopsy samples submitted for histopathology from pet guinea pigs that had presented with externally palpable masses.
The purpose was to determine the most common tissue origins of these masses and the most frequent pathological diagnoses, together with signalment data for the most commonly diagnosed lesions.
Of the 619 samples submitted from 493 animals, 54 (8.7%) had arisen from the mammary glands3 and 15 (2.4%) from the thyroid glands, with the remaining 550 (88.9%) involving the skin and subcutis, muscle (n = 1), salivary glands (n = 4), lips (n = 2), ears (n = 4) and peripheral lymph nodes (n = 23).
Forty-seven (7.6%) of the masses were diagnosed as inflammatory in nature, including dermatitis, panniculitis, lymphadenitis, cheilitis, myositis, sialoadenitis, abscess and chronic inflammation with osseous metaplasia.
Non-neoplastic, non-inflammatory lesions accounted for a further 31 (5.0%), namely cysts, hamartomas, hyperplastic lesions, polyps, ectopic bone formation and salivary gland steatosis.
The remainder of the samples were neoplastic in nature (541; 87.4%), with 99 masses classified as epithelial in origin, 347 as mesenchymal, 23 as round cell, five as melanocytic and eight as unclassified malignant neoplasms.
Of these, mesenchymal neoplasms were further subdivided into benign (288) and malignant (59).
Lipomas were the most common neoplasm diagnosed, accounting for 286 of all samples submitted.
Of all 619 samples included in the study, the eight most commonly diagnosed lesions were lipoma (46.2%), trichofolliculoma (12.3%), sarcoma (of various subtypes: 9.5%), inflammation (all sites 7.6%), lymphoma / leukaemia (3.4%), mammary carcinoma (4%), mammary adenoma (3.2%) and thyroid carcinoma (1.5%).
Overall these eight diagnoses accounted for 87.7% of all submissions from the externally palpable masses from the pet guinea pigs submitted for histopathology.
Melanie said: “Guinea pigs are an increasingly popular household pet.
"Skin diseases, including palpable masses, are a common reason for veterinary presentation. But few studies have been published to date that provide information for clinicians about these conditions.
“This study illustrates the importance of neoplasms of the skin and subcutis in pet guinea pigs, with over 87% of the cases analysed having one of eight diagnoses.
"While most of these neoplasms are benign, a substantial minority are malignant and identifying those lesions is especially important in treatment planning.
"Clinicians dealing with pet guinea pigs should also be aware that some externally palpable masses may arise from the thyroid or mammary glands rather than the skin or subcutis, and that male guinea pigs may also develop mammary lesions.”
The paper has been selected as ‘Editor’s Choice’ by the Journal of Comparative Pathology and will be free to access until September on Lumpy, bumpy guinea pigs: a retrospective study of 619 biopsy samples of externally palpable masses submitted from pet guinea pigs for histopathology - ScienceDirect.
Miss Herdman faced three charges.
The first was that she indicated to a friend that she would supply diazepam and/or tramadol for use by their husband.
The second was that she supplied diazepam and/or tramadol and/or gabapentin.
The third was that she gave advice on the dosages of diazepam and/or tramadol and/or gabapentin.
Miss Herdman was not present at the hearing and was unrepresented, but the Committee determined that it was appropriate to proceed in her absence as she had been notified, was aware that the hearing was taking place and her absence was voluntary.
However, Miss Herdman had been in contact to indicate her pleas to the charges.
She admitted the intention to supply diazepam and/or tramadol and that she had provided advice on the dosages.
She also admitted that she had supplied diazepam but strongly denied that she had supplied tramadol and/or gabapentin.
Taking all the evidence into account (including messages sent by Miss Herdman and her admissions), the Committee found proven the charges in relation to the intent to supply and the advice on dosages.
The Committee also found proven the charge in relation to the supply of diazepam, but found not proved the charge relating to the supply of tramadol and gabapentin for several reasons, including the fact that the messages sent by Miss Herdman did not point unequivocally to her actually suppling each of the drugs to which she referred.
There was no suggestion that the diazepam was stolen from her place of work.
The Committee found that Miss Herdman’s actions had breached paragraphs 1.5 and 6.5 of the Code of Professional Conduct for Veterinary Nurses.
The committee judged that there were a number of aggravating features of Miss Herdman’s conduct, including that she was not qualified or authorised to prescribe medication to animals, let alone to human beings and that providing a controlled drug to a person who was already taking various painkilling medications was reckless.
The Committee also felt that a reasonable and informed member of the public would be very concerned to learn that a veterinary nurse had supplied a controlled drug to a friend for their personal use.
Regarding the sanction for Miss Herdman, Paul Morris, chairing the Veterinary Nursing Disciplinary Committee and speaking on its behalf, said: “Drawing all the material together, and considering the matter as a whole, the Committee had to impose a proportionate sanction for an isolated incident of serious professional misconduct which arose out of a misguided attempt to help a friend.
"The conduct in question was entirely out of keeping with Miss Herdman’s usual practice and there is no real risk that it will be repeated.
"However, this case was much too serious to take no further action and no useful purpose would be served by postponing a sanction.
“The Committee considered that a warning or reprimand would not be sufficient to satisfy the public interest as veterinary nurses are trusted by the public to deal with medication responsibly and failure to do constitutes a severe breach of trust.
“The Committee therefore considered a period of suspension sufficient to meet the public interest in maintaining the reputation of the profession and declaring and upholding proper standards of conduct for members of the profession.
“The Committee also considered whether a removal order would be appropriate but concluded it would be disproportionate and that such a step would remove from the profession an experienced, competent and valuable veterinary nurse for no discernible benefit.
“It was decided that Miss Herdman’s registration be suspended for a period of three months – a period which is sufficient to mark the gravity of the misconduct while taking into account the circumstances in which it arose.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings/
The day will be led by Sonya Miles, BVSc CertAVP (ZM), CertAqV, MRCVS, RCVS Recognised Advanced Practitioner in Zoological Medicine and WAVMA Certified Aquatic Species Veterinarian.
Lectures will look at techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques in a wide variety of exotic species.
Delegates will also be provided with lecture notes, a CPD certificate, refreshments and lunch, as well as goodie bags provided by sponsors Pinmoore Animal Laboratory Services Limited.
Sonya says the aim of the day is to dispel many myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
To book your place or for more information, email: info@justexotics.co.uk or book online at https://justexoticsevents.co.uk/dont-miss-out-on-our-latest-event
Phovia, which was launched in the UK last year, is a two-part FLE system consisting of a chromophore gel that is applied to the affected skin and a blue light LED lamp.
Vetoquinol says that when used together they produce light of varying wavelengths that penetrates the skin to different depths, helping to control bacteria and reduce inflammation on the surface of the skin and stimulating regeneration in the epidermal and dermal layers.
The unit is portable, and applications take four minutes once a week.
The authors of the Vetoquinol-funded study say that FLE has already been shown to support and accelerate natural skin healing, but this latest research shows that the benefits go beyond improvement in clinical signs.
The study looked at 35 dogs with a diverse range of skin conditions: 13 had interdigital furunculosis, 10 had deep pyoderma, 6 had wounds, 4 had pyotraumatic dermatitis, and 2 had perianal fistula on presentation.
Eight of 35 dogs were new cases, whereas the remaining 27 were undergoing recrudescence of a prior episode, including pyotraumatic dermatitis, wounds, deep pyoderma, interdigital furunculosis and perianal fistulae.
Thirty dogs (86%) achieved a clinical resolution: 18 with the Fluorescent Light Energy alone and 12 with the concomitant use of FLE and topical antiseptic shampoo.
Five dogs (14%) had a partial response and needed other therapies.
92% percent of owners attested to their pet’s enhanced quality of life, with 74% of dogs displaying at least a 50% improvement in owner-reported behaviour, mood, sleep and playing activities.
The study also reported a 46% reduction in caregiver burden.
Felicity Caddick, Technical Services Manager at Vetoquinol said: “Managing skin conditions often requires the long-term use of shampoos or topical therapies.
"Many owners find this aspect of pet ownership challenging, especially with larger dogs, or less cooperative animals.
"FLE can reduce or in some cases eliminate the need for topical therapies at home, not only simplifying the treatment process but also enhancing convenience and compliance.
"Sharing responsibility for administering ongoing treatment with their vet practice also removes some of the worry associated with their pet’s health.”
Vetoquinol also highlights that Phovia can offer vets a drug-free management option for skin disorders that aligns with the principles of antibiotic stewardship.
Reference
The webinar will allow veterinary teams to learn from three expert speakers how they can make small practical changes to have positive impacts in their own settings.
Helen Ballantyne, Chair of the UK One Health Coordination Group (UKOHCG) and both a human and animal health nurse, will provide a ‘human’ view of One Health and the strategies in the NHS.
She will highlight areas of excellent practice she has experienced, and from a One Health angle where the veterinary profession could learn from the NHS, and vice versa.
Fergus Allerton MRCVS, an Internal Medicine Specialist and lead on antimicrobial resistance (AMR) at Linnaeus will talk about, amongst other things, the optimal use of antimicrobials for infection control.
In collaboration with the NHS, he launched Veterinary Antibiotic Amnesty activity which saw a 19% reduction of antimicrobial use across the Linnaeus veterinary group.
Fergus will also talk about the PROTECT ME guidelines on the responsible use of antibacterials, such as for surgical antibiotic prophylaxis.
Simon Doherty, past-president of the British Veterinary Association and one of two BVA representatives at the Federation of Veterinarians in Europe, will focus on the history of One Health and One Agriculture; highlighting how improved communication and collaboration at the intersection of people, animals and the environment can drive productivity and sustainability in food production.
Simon will also share some of Vet Sustain’s farm animal resources and how the principles can be applied.
To register, visit: https://horiba.link/one-health-webinar
The 'Lifelong Ear Partnership' resources, which were developed in conjunction with a panel of vets, are designed to help practice teams improve their owner communication and achieve owner buy-in about otitis.
To that end, Dechra has developed various owner communication tools for use in practice or to refer owners to after the consultation.
They include an owner website: www.ear-inflammation.co.uk and a postcard with QR code links to educational videos which cover clinical recommendations, treatment options and the importance of revisits.
There is also a brochure for owners and an online 4D ear model: www.4d-earmodel.com, which demonstrates a healthy ear and an ear with mild, moderate or severe otitis.
Finally, Dechra has also launched an ear cytology webinar series on Dechra Academy: www.dechra.co.uk/academy.
The course consists of tips for everything from greeting the patient to performing and interpreting cytology slides.
www.dechra.co.uk/otitis-externa.
New statistics from the Voice of the Veterinary Profession Spring 2022 survey showed that while veterinary work is often seen as a vocation, 77% of vets list pay among their top five priorities when choosing a job.
Other deciding factors include geographical location (74%), area of practice (62%), low staff turnover (45%) and structured career progression (28%).
However only 42% of vets who responded to the survey considered their pay and benefits to be either ‘good’, ‘very good’, or ‘excellent’.
BVA President Malcolm Morley, said: “Fair, transparent and equal pay is one of the keystones of good veterinary workplaces.
"Whether you’re an employee, a manager or an employer, it’s vital that everyone feels confident that their workplace approaches pay in a clear and consistent way.
"This isn’t about paying everyone more; it’s about using objective criteria and transparent pay scales to ensure the whole team understands how decisions about reward and recognition are made and what they can do to access higher pay.”
The new resource, created for BVA members as part of its Good Veterinary Workplaces campaign, includes information for veterinary employers on the benefits a clear pay structure can bring for the whole team.
It demonstrates the positive impact transparency around reward and recognition can have on employee fulfilment and retention, and outlines the legal requirements of employers to ensure that pay is equitable.
It also offers tips for employees and managers for approaching conversations about pay and emphasises the importance of considering ‘total reward’ during these conversations.
Total reward is the entire sum of a job’s offering including, but not limited to, salary, commission structure, benefits package, CPD, work/life balance, promotion opportunities, travel expenses, accommodation, and so on.
Malcolm added: “We know that pay can be a fraught, and even somewhat taboo, subject but it is one that we all have a responsibility to tackle if we want to ensure that veterinary professionals are fairly rewarded for their work.
"We hope that this new guide will support all our members and equip them with the knowledge required to ensure they can confidently navigate conversations about pay.”
https://www.bva.co.uk/talking-pay
The Linnaeus OAPC initiative was launched in 2021 and originally allocated £30K for 2022.
However, that figure was doubled after the company received a growing number of high quality submissions.
33 papers were accepted for funding in 2022, of which 24 have so far been published and the remainder are undergoing peer review.
The authors comprise clinicians, specialists, residents and interns across nine referral and primary care sites within the group.
The OAPC was introduced by Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus (pictured right).
She said: “By making clinical research open access, we can ensure it makes the widest possible impact – while also supporting the author’s profile and career development.
"We are continuing to offer OAPC funding to our associates in 2023 and look forward to seeing the fantastic research published as a result.”
To ask Shelly a question, first read her article here: https://www.veterinary-practice.com/article/pain-management-for-veterinary-nurses
Then join the VetNurse Clinical Article Club here: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club
Then post your question or discuss the article in this thread: https://www.vetnurse.co.uk/001/vetnurse-clinical-article-club/f/clinical-article-club-discussions/32396/pain-management-for-veterinary-nurses
£50 for the post which provokes the most discussion by the end of the week!
Remember, all time spent reading or participating in Clinical Article Club discussions can be claimed towards your annual CPD requirement: Press 'Claim CPD' at the top of the discussion thread.
32% said they find dog care to be too restrictive
29% said it would be too difficult to go on holiday
24% said they don’t want to walk the dog every day and 25% that having a dog is too expensive.
41% of those who said they regret getting a dog bought it during lockdown.
Zoetis has announced a supply problem with Equip Artervac, its vaccine against equine viral arteritis
The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
The Association says it has produced the leaflet after seeing an increasing number of dogs diagnosed with clinical or subclinical infection, along with reports of its zoonotic impact.
The document outlines the most important considerations concerning B. canis including transmission, diagnosis, management, public health implications and legislative requirements.
It takes into consideration information available from relevant Government Departments.
BSAVA says the document is by no means exhaustive but is intended to provide useful information and signpost to further resources.
www.bsavalibrary.com/brucella_canis
Photo: Walker16/Wikipedia. CC BY-SA 4.0.
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.
The definition agreed by VN Council is as follows:
Veterinary nursing aims to ease the suffering and pain of animals, and to improve their health and welfare.
This includes providing any medical treatment or any minor surgery (not involving entry into a body cavity) to animals under the direction of a veterinary surgeon who has that animal under their care.
Veterinary nursing can be either proactive or reactive, and autonomous or collaborative. It is carried out in a wide variety of settings, for animals at all life stages, and considers the background and needs of the animal’s owner or keeper.
Matthew Rendle RVN, the Chair of VN Council, said: “Although it is just a few short lines, this definition of veterinary nursing has been in the pipeline for some time.
"While we as veterinary nurses have always been able to define ourselves by the type of tasks we carry out, or our relation to veterinary surgeons in terms of delegation, there hasn’t necessarily been a clear statement articulating the art and science of veterinary nursing.
“With the RCVS looking to expand its regulatory remit to include other veterinary paraprofessionals over the long term, we thought it was particularly important that we set out the stall for veterinary nursing and we hope that this clear statement will, in particular, aid the public in understanding the role of a veterinary nurse.
“It should be noted that this definition is VN Council’s own considered interpretation of the art and science of veterinary nursing.
"Other interpretations from other organisations, provided they conform with both Schedule 3 of the Veterinary Surgeons Act and the RCVS Code of Professional Conduct, could sit comfortably alongside ours, and we hope there continues to be healthy discussion about the contribution of the profession to the veterinary team, as our role evolves.”
What do you think of the definition and do you think it will help change the public and the profession's perceptions. Have your say here: https://www.vetnurse.co.uk/001/f/nonclinical-discussions/32399/what-do-you-think-of-the-new-rcvs-vn-council-definition-of-the-role-of-vet-nurses
The survey was conducted following the recent RCVS Council decision to redefine ‘Under Care’ to allow vets to prescribe remotely.
692 veterinary surgeons took part in the survey, 88.7% of which worked in practice, 8.7% worked elsewhere and 2.6% are retired.
42.4% worked in corporate practice, 42.4% at an independent practice (spooky), 9.6% locum and 2.6% at a charity.
94% worked in first opinion practice, 5.7% in referral practice.
When asked: “Do you agree with the RCVS Council decision to allow veterinary surgeons to prescribe medication without having seen / examined the animal in person?”, 78.2% said no, 13.6% said yes and 8.2% said ‘ambivalent’.
This raises an interesting discussion about the role of RCVS Council, which the College has long said is ‘representative of’, but not there 'to represent’ the profession in self-regulating.
By any measure, this decision was not ‘representative of’ the wider body of opinion.
It could be argued that electorates vote for representatives to make more informed decisions than they themselves are able, and certainly MPs have voted in ways that are not representative of the wider body of public opinion.
But this is the veterinary profession. MPs have to represent a wide cross-section of society, some groups of which might struggle to field one working brain cell between them.
By contrast, veterinary surgeons are a highly intelligent, highly educated subset of the population, who you might assume are better qualified to make decisions on matters such as these.
So why this level of disagreement? We asked respondents to select any benefits and drawbacks they think remote prescribing will bring, from a list but with the option for them to write in any we hadn’t thought of.
When asked to select benefits of remote prescribing, the majority (70.9%) selected: “Reduced cost to the pet owner (driving/parking etc)’.
39.3% said it would bring an improvement to vets’ quality of life through more flexible working.
27.5% said animal welfare would be improved through increased access to veterinary services.
14.3% said it would bring an ‘Improved client/vet relationship’.
Of those people who selected a benefit, 49.9% said the biggest benefit of remote prescribing is a reduced cost to the pet owner (driving / parking etc).
Other benefits highlighted in the comments section were
Notably, in the comments section for the benefits of remote prescribing, out of the 104 comments, 33 actually commented 'no benefit' or negatively.
When asked to select the drawbacks of remote prescribing, 94.3% selected: ‘Harm to animals caused by misdiagnoses and missed diagnoses.
68% said: Worsened client / vet relationship
60.6% said: Threat to independent practice (corporates funnelling clients from online consults to their practices).
Other drawbacks identified by respondents were:
Amongst the written drawbacks, the biggest themes concerned abuse of drugs and antimicrobial resistance.
When those who had selected a drawback were then asked which was the biggest, 83.3% said ‘Harm to animals caused by misdiagnoses and missed diagnoses”
So in simple terms, in weighing up the pros and cons, it’s between the reduced cost to the owner on the one hand, cited by 70.9%, and harm to animal welfare on the other, cited by 94%. And the harm to animal welfare was selected by significantly more vets as the biggest concern, than reduced cost was selected as the biggest benefit.
In other words, vets think remote prescribing will make veterinary care cheaper, but at the overall cost to animal welfare.
British Veterinary Association President Malcolm Morley said: “New technology presents many opportunities to enhance existing veterinary services, with potential benefits for vets, clients and patients.
"However, we recognise there are concerns within the profession, particularly around the potential unintended consequences of the RCVS’s revised guidance on ‘under care’ in relation to animal welfare and access to veterinary services.
"This survey echoes these concerns as well as supporting the British Veterinary Association’s call for the RCVS to commit to a post-implementation review.”
Omniflora paste is designed to provide fast acting support in acute digestive upset or strategically ahead of perceived stressful events such as travel or veterinary appointments.
It contains probiotics, prebiotics, adsorbents, parabiotics, postbiotics, electrolytes and nutrients.
Omniflora tablets are available for animals who resist an oral syringe.
The tablets contain probiotics, prebiotics and adsorbent clay and fibre.
Veterinary nurse and sales manager, Tara Evans, said: “Digestive upset in cats and dogs is common.
"We wanted to provide vets and pet owners with an easy-to-use solution that can be used in practice or at home.
"One tube of paste lasts for three consecutive days to support cats and dogs as they recover from gastrointestinal upset.”
"As well as supporting the gut in acute episodes of digestive upset such as diarrhoea, Omniflora can be used ahead of time in stressful events such as travelling, visiting the groomers, or any planned veterinary procedures such as surgeries or blood tests.”
Omniflora can be ordered here https://www.vitaanimalhealth.com/product/omniflora